March Networking Event: Biomedical and Healthcare

Category: Tag:

Regular price at the door: $20.00  Up to 48h before the event $15.00  

BioTech Annecto Montreal is pleased to announce a presentation given by Damon Smith, PhD, CEO at Altus Formulation Inc entitled:


Development of a New, Injectable COX-2 Analgesic to Reduce Opioid Use after Surgery


Postoperative pain affects over 80% of people undergoing surgery and is too frequently treated with prolonged doses of opioids. Such strategies can lead to dependence and addiction.


We are using SmartCelle nanotechnology to develop a new formulation of the highly insoluble COX-2 inhibitor celecoxib (Celebrex®). SmartCelle, by increasing the solubility of celecoxib many thousands of times allows, for the first time, intravenous administration of this non-opioid drug. Red blood cell binding by SmartCelle technology also appears to significantly increase celecoxib circulation time permitting >12hr activity from a single injection. Such approaches are expected to reduce significantly the need for opioid analgesics after surgery thereby greatly enhancing patient experience and reducing addiction potential.


Damon is a CEO and a founder member of the Altus team having worked for 10 years as Senior Vice President Research and Development at Labopharm Inc. Prior to joining Labopharm he spent time at Conjuchem, a Montreal start up, and prior to this was Executive Director of Development at Protherics, a UK based antibody development company listed on the London Stock Exchange.


Who is invited?

Professionals in the following industries: pharmaceuticals, CROs, biotechnology, and medical technology, Health care and biomedical research

People seeking opportunities to enlarge their professional network in life science industries.


When and Where?

6:30pm to 9pm on Tuesday March 20, 2018


Siboire Brewpub

5101 St Laurent Blvd

Montreal, QC H2T 1R9


Cost: $15 (up to 48h before the event) / $20 regular price / FREE if you purchase a yearly membership


Please login to the site, using LinkedIn preferably, to be able to register for the event.